We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Proposed Appraisals in FDA’s Device Voluntary Improvement Program Draw Criticism
Proposed Appraisals in FDA’s Device Voluntary Improvement Program Draw Criticism
Leading devicemakers have pushed back against the FDA’s proposed annual appraisals of companies that participate in the agency’s Voluntary Improvement Program (VIP).